Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710283019 | Hydralazine- and isosorbide-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710284013 | Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Is a | Hydralazine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Is a | Product containing isosorbide in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Is a | Product containing hydralazine and isosorbide | false | Inferred relationship | Some | ||
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Has active ingredient | Isosorbide (substance) | false | Inferred relationship | Some | 1 | |
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Has active ingredient | Hydralazine (substance) | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | False | Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) | Is a | False | Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
ALTERNATIVE association reference set (foundation metadata concept)
FHIR